During this Covid-19 pandemic, we have seen the immense pressure on healthcare resources in countries across SEA and the world. The rising rates of complex chronic diseases contribute to underlying conditions that have increased population risks to COVID-19 infection and spread. This compounds the complexity of patient care and adds further challenges to pandemic management. 

To get insights on the current challenges of healthcare operations in SEA, I am speaking with Dr Andrew Wu, Co-founder and CEO of Mesh Bio, a digital healthcare startup on his insights. Mesh Bio provides automation and predictive analytics solutions that have the potential to transform care delivery.